← USPTO Patent Applications

MAGEA4 SPECIFIC T CELL RECEPTORS

Application US20260085105A1 Kind: A1 Mar 26, 2026

Assignee

AMGEN INC.

Inventors

Sungeun KIM, Matthew James RARDIN

Abstract

Provided herein are recombinant T-cell receptors (TCRs) that can selectively recognize the MAGE-A4-derived peptide GVYDGEEHSV or KVEEHVVRV when presented by HLA-A*0201 sufficiently to activate the recombinant T cell. TCRs provided herein were thoroughly screened for lack of cross-reactivity with similar peptides that may be presented by normal cells or tissue and for alloreactivity.

CPC Classifications

C07K 14/7051 A61K 35/17 A61K 40/11 A61K 40/32 A61K 40/4268 A61P 35/00 C07K 14/5434 C12N 5/0636 C12N 15/867 C07K 2317/33 C07K 2317/565 C07K 2317/72 C12N 2740/15043

Filing Date

2023-06-23

Application No.

18876904